Paul L Berns - Net Worth and Insider Trading
Paul L Berns Net Worth
The estimated net worth of Paul L Berns is at least $3 Million dollars as of 2024-11-05. Paul L Berns is the President and CEO of Anacor Pharmaceuticals Inc and owns about 230,311 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $2 Million. Paul L Berns is the Director of Jazz Pharmaceuticals PLC and owns about 8,290 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $922,511. Paul L Berns is also the Director of Cellectar Biosciences Inc and owns about 1,174 shares of Cellectar Biosciences Inc (CLRB) stock worth over $2,384. Details can be seen in Paul L Berns's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul L Berns has not made any transactions after 2021-08-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul L Berns
Paul L Berns Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul L Berns owns 8 companies in total, including Jazz Pharmaceuticals PLC (JAZZ) , Unity Biotechnology Inc (UBX) , and VYNE Therapeutics Inc (VYNE) among others .
Click here to see the complete history of Paul L Berns’s form 4 insider trades.
Insider Ownership Summary of Paul L Berns
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 2021-08-05 | director |
| UBX | Unity Biotechnology Inc | 2020-06-18 | director |
| VYNE | VYNE Therapeutics Inc | 2019-06-25 | director |
 | | 2016-06-24 | director & President and CEO |
| | 2016-05-17 | director |
| | 2016-04-20 | director |
| | 2021-12-17 | director |
| | 2023-09-14 | director |
Paul L Berns Latest Holdings Summary
Paul L Berns currently owns a total of 3 stocks. Among these stocks, Paul L Berns owns 230,311 shares of Anacor Pharmaceuticals Inc (ANAC) as of March 22, 2016, with a value of $2 Million and a weighting of 70.98%. Paul L Berns owns 8,290 shares of Jazz Pharmaceuticals PLC (JAZZ) as of August 5, 2021, with a value of $922,511 and a weighting of 28.95%. Paul L Berns also owns 1,174 shares of Cellectar Biosciences Inc (CLRB) as of April 20, 2016, with a value of $2,384 and a weighting of 0.07%.
Latest Holdings of Paul L Berns
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANAC | Anacor Pharmaceuticals Inc | 2016-03-22 | 230,311 | 9.82 | 2,261,654 |
| JAZZ | Jazz Pharmaceuticals PLC | 2021-08-05 | 8,290 | 111.28 | 922,511 |
| CLRB | Cellectar Biosciences Inc | 2016-04-20 | 1,174 | 2.03 | 2,384 |
Holding Weightings of Paul L Berns
Paul L Berns Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul L Berns has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the sale of 37,500 shares on March 22, 2016, which brought Paul L Berns around $2 Million.
According to the SEC Form 4 filings, Paul L Berns has made a total of 3 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 1,450 shares on August 5, 2021, which brought Paul L Berns around $223,300.
According to the SEC Form 4 filings, Paul L Berns has made a total of 0 transactions in Cellectar Biosciences Inc (CLRB) over the past 5 years. The most-recent trade in Cellectar Biosciences Inc is the acquisition of 1,174 shares on April 20, 2016, which cost Paul L Berns around $248,826.
Insider Trading History of Paul L Berns
- 1
Paul L Berns Trading Performance
GuruFocus tracks the stock performance after each of Paul L Berns's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul L Berns is 25.37%. GuruFocus also compares Paul L Berns's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul L Berns within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul L Berns's insider trading performs compared to the benchmark.
Performance of Paul L Berns
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 68.29 | | | | | |
| Relative Return to S&P 500(%) | 70.67 | | | | | |
Paul L Berns Ownership Network
Ownership Network List of Paul L Berns
Ownership Network Relation of Paul L Berns
Paul L Berns Owned Company Details
What does Jazz Pharmaceuticals PLC do?
Who are the key executives at Jazz Pharmaceuticals PLC?
Paul L Berns is the director of Jazz Pharmaceuticals PLC. Other key executives at Jazz Pharmaceuticals PLC include SVP & Technical Operations Mary Elizabeth Henderson , VP & Finance& PAO Patricia Carr , and SVP & General Counsel Neena M Patil .
Jazz Pharmaceuticals PLC (JAZZ) Insider Trades Summary
Over the past 18 months, Paul L Berns made no insider transaction in Jazz Pharmaceuticals PLC (JAZZ). Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 4,293 shares made by Patricia Carr , a net sale of 8,850 shares made by Neena M Patil , and a net sale of 1,658 shares made by Jennifer E. Cook .
In summary, during the past 3 months, insiders sold 1,410 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 0 shares, with a net sale of 1,410 shares. During the past 18 months, 33,900 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 21,900 shares.
Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jazz Pharmaceuticals PLC Insider Transactions
Paul L Berns Mailing Address
Above is the net worth, insider trading, and ownership report for Paul L Berns. You might contact Paul L Berns via mailing address: 11080 Circlepoint Rd., Ste, 200, Westminster Co 80020.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
